Diagnósticos da América Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Diagnósticos da América wird ein jährliches Gewinn- und Umsatzwachstum von 113.5% bzw. 6.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 147.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 0.5% betragen.
Wichtige Informationen
113.5%
Wachstumsrate der Gewinne
147.3%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 26.8% |
| Wachstumsrate der Einnahmen | 6.6% |
| Zukünftige Eigenkapitalrendite | 0.5% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 23 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Some Diagnósticos da América S.A. (BVMF:DASA3) Shareholders Look For Exit As Shares Take 27% Pounding
Nov 15
Diagnósticos da América (BVMF:DASA3) Has Some Way To Go To Become A Multi-Bagger
Nov 13Revenues Working Against Diagnósticos da América S.A.'s (BVMF:DASA3) Share Price Following 27% Dive
Aug 15Diagnósticos da América (BVMF:DASA3) Use Of Debt Could Be Considered Risky
Jul 23Benign Growth For Diagnósticos da América S.A. (BVMF:DASA3) Underpins Stock's 30% Plummet
Jun 24Why Investors Shouldn't Be Surprised By Diagnósticos da América S.A.'s (BVMF:DASA3) 25% Share Price Plunge
May 10Risks To Shareholder Returns Are Elevated At These Prices For Diagnósticos da América S.A. (BVMF:DASA3)
Mar 21Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Feb 04Is Diagnósticos da América (BVMF:DASA3) A Risky Investment?
Jan 08Insufficient Growth At Diagnósticos da América S.A. (BVMF:DASA3) Hampers Share Price
Dec 18Diagnósticos da América (BVMF:DASA3) Is Reinvesting At Lower Rates Of Return
Sep 20Is Diagnósticos da América (BVMF:DASA3) Using Too Much Debt?
Aug 25Diagnósticos da América S.A. (BVMF:DASA3) Looks Inexpensive But Perhaps Not Attractive Enough
Jun 27Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Apr 17Diagnósticos da América (BVMF:DASA3) Seems To Be Using A Lot Of Debt
Mar 13Returns On Capital At Diagnósticos da América (BVMF:DASA3) Paint A Concerning Picture
Dec 14Does Diagnósticos da América (BVMF:DASA3) Have A Healthy Balance Sheet?
Nov 09Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Aug 19Here's Why Diagnósticos da América (BVMF:DASA3) Has A Meaningful Debt Burden
Jul 15Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
May 06Results: Diagnósticos da América S.A. Delivered A Surprise Loss And Now Analysts Have New Forecasts
Apr 01These 4 Measures Indicate That Diagnósticos da América (BVMF:DASA3) Is Using Debt Reasonably Well
Mar 02Diagnósticos da América (BVMF:DASA3) Could Be Struggling To Allocate Capital
Jan 25Diagnósticos da América (BVMF:DASA3) Might Be Having Difficulty Using Its Capital Effectively
Oct 10Is Diagnósticos da América (BVMF:DASA3) A Risky Investment?
Sep 13There Are Reasons To Feel Uneasy About Diagnósticos da América's (BVMF:DASA3) Returns On Capital
Jun 27Diagnósticos da América (BVMF:DASA3) Has A Somewhat Strained Balance Sheet
May 31We're Watching These Trends At Diagnósticos da América (BVMF:DASA3)
Feb 25Shareholders of Diagnósticos da América (BVMF:DASA3) Must Be Delighted With Their 634% Total Return
Jan 03
These 4 Measures Indicate That Diagnósticos da América (BVMF:DASA3) Is Using Debt Extensively
Dec 07Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 17,386 | 295 | N/A | N/A | 6 |
| 12/31/2025 | 16,454 | 35 | N/A | 1,779 | 8 |
| 12/31/2024 | 15,301 | -429 | N/A | 1,372 | 3 |
| 9/30/2024 | 14,971 | -879 | -805 | -234 | N/A |
| 6/30/2024 | 14,771 | -972 | -1,109 | -575 | N/A |
| 3/31/2024 | 14,446 | -1,150 | -1,209 | -487 | N/A |
| 12/31/2023 | 14,252 | -1,138 | -1,775 | -964 | N/A |
| 9/30/2023 | 14,213 | -843 | -1,320 | -367 | N/A |
| 6/30/2023 | 13,869 | -752 | -1,308 | -169 | N/A |
| 3/31/2023 | 13,527 | -590 | -1,369 | -223 | N/A |
| 12/31/2022 | 13,129 | -387 | -1,165 | -29 | N/A |
| 9/30/2022 | 12,523 | -340 | -523 | 428 | N/A |
| 6/30/2022 | 11,862 | -177 | -404 | 555 | N/A |
| 3/31/2022 | 11,178 | -177 | -181 | 724 | N/A |
| 12/31/2021 | 10,419 | -227 | 392 | 1,298 | N/A |
| 9/30/2021 | 9,973 | -36 | -17 | 819 | N/A |
| 6/30/2021 | 9,280 | -60 | -112 | 628 | N/A |
| 3/31/2021 | 7,959 | -85 | 157 | 903 | N/A |
| 12/31/2020 | 7,039 | -151 | 11 | 767 | N/A |
| 9/30/2020 | 5,887 | -191 | -210 | 469 | N/A |
| 6/30/2020 | 4,986 | -198 | 152 | 782 | N/A |
| 3/31/2020 | 4,795 | -19 | 312 | 827 | N/A |
| 12/31/2019 | 4,365 | 125 | 195 | 699 | N/A |
| 9/30/2019 | 4,238 | 127 | 493 | 925 | N/A |
| 6/30/2019 | 4,096 | 158 | 322 | 726 | N/A |
| 3/31/2019 | 3,992 | 168 | 208 | 553 | N/A |
| 12/31/2018 | 3,933 | 184 | 231 | 530 | N/A |
| 9/30/2018 | 3,886 | 210 | 78 | 386 | N/A |
| 6/30/2018 | 3,733 | 175 | N/A | 453 | N/A |
| 3/31/2018 | 3,545 | 136 | N/A | 516 | N/A |
| 12/31/2017 | 3,399 | 131 | N/A | 653 | N/A |
| 9/30/2017 | 3,259 | 129 | N/A | 626 | N/A |
| 6/30/2017 | 3,178 | 152 | N/A | 669 | N/A |
| 3/31/2017 | 3,138 | 169 | N/A | 733 | N/A |
| 12/31/2016 | 3,041 | 95 | N/A | 842 | N/A |
| 9/30/2016 | 2,965 | 90 | N/A | 676 | N/A |
| 6/30/2016 | 2,899 | 39 | N/A | 624 | N/A |
| 3/31/2016 | 2,864 | 29 | N/A | 531 | N/A |
| 12/31/2015 | 2,794 | 24 | N/A | 489 | N/A |
| 9/30/2015 | 2,731 | 4 | N/A | 433 | N/A |
| 6/30/2015 | 2,731 | 38 | N/A | 391 | N/A |
| 3/31/2015 | 2,691 | 58 | N/A | 387 | N/A |
| 12/31/2014 | 2,698 | 88 | N/A | 459 | N/A |
| 9/30/2014 | 2,666 | 135 | N/A | 462 | N/A |
| 6/30/2014 | 2,584 | 127 | N/A | 357 | N/A |
| 3/31/2014 | 2,528 | 130 | N/A | 319 | N/A |
| 12/31/2013 | 2,448 | 125 | N/A | 255 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: DASA3 wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (10.4%).
Ertrag vs. Markt: DASA3 wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: DASA3 wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: DASA3Die Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt BR (7.4% pro Jahr).
Hohe Wachstumseinnahmen: DASA3Die Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: DASA3Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (0.5%).